title: Intraoperative parathormone measurements and postoperative hypocalcemia.
abstract: BACKGROUND
  Hypocalcemia following thyroid and parathyroid surgery is a well-recognized potential complication.
  
  
  OBJECTIVE
  To determine the utility of intraoperative quick parathormone assay in predicting severe hypocalcemia development following parathyroidectomy for a single-gland adenoma causing primary hyperparathyroidism.
  
  
  METHODS
  A retrospective cohort study was performed. IO-QPTH values were measured at time 0 (T0) before incision, and 10 (T10) and 30 minutes (T30) following excision of the hyperfunctioning gland. Percent decrease in IO-QPTH at 10 minutes (T10), maximum percent decrease of IO-QPTH value, and lowest actual IO-QPTH value obtained at surgery were used to determine any correlation with the development of postoperative hypocalcemia requiring treatment.
  
  
  RESULTS
  Percent decrease in IO-QPTH at 10 minutes, maximum percent decrease in IO-QPTH and lowest IO-QPTH value did not correlate with the lowest postoperative calcium levels measured 18 hours after surgery (r = 0.017, P = 0.860; r = 0.018, P = 0.850; and r = 0.002, P= 0.985 respectively). For the purposes of our analysis, patients were subdivided into three groups. Group 1 comprised 68 patients with normal calcium levels (serum Ca 8.6-10.3 mg/dl), group 2 had 28 patients with hypocalcemia (8.1-8.6 mg/dl), and group 3 included 12 patients with severe hypocalcemia (calcium level < or = 8.0 mg/dl) requiring calcium supplementation due to symptoms of hypocalcemia. There was no difference between the three groups in the lowest IO-QPTH value (P = 0.378), percent decrease in IO-QPTH (P = 0.305) and maximum percent dercrease in IO-QPTH (P = 0.142).
  
  
  CONCLUSIONS
  IO-QPTH evaluation was not useful in predicting the group of patients susceptible to develop severe postoperative hypocalcemia.
authors.affiliation: Division of Surgery, Assaf Harofeh Medical Center, Zerifin and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
authors.forename: Albert
authors.initials: A
authors.lastname: Stepansky
authors.forename: Ruth
authors.initials: R
authors.lastname: Gold-Deutch
authors.forename: Natan
authors.initials: N
authors.lastname: Poluksht
authors.forename: Philippe
authors.initials: P
authors.lastname: Hagag
authors.forename: Carlos
authors.initials: C
authors.lastname: Benbassat
authors.forename: Anat
authors.initials: A
authors.lastname: Mor
authors.forename: Dorit
authors.initials: D
authors.lastname: Aharoni
authors.forename: Ilan
authors.initials: I
authors.lastname: Wassermann
authors.forename: Zvi
authors.initials: Z
authors.lastname: Halpern
authors.forename: Ariel
authors.initials: A
authors.lastname: Halevy
mesh_terms: D000236:Adenoma / Q000150:complications / Q000601:surgery*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D015331:Cohort Studies; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000209:etiology / Q000601:surgery; D006996:Hypocalcemia / Q000097:blood / Q000175:diagnosis* / Q000209:etiology*; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010282:Parathyroid Neoplasms / Q000150:complications / Q000601:surgery*; D016105:Parathyroidectomy / Q000009:adverse effects*; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis*; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D010281:Parathyroid Hormone